Last week, the Therapeutic Goods Administration changed the classification of Psilocybin and MDMA to allow psychiatrists to prescribe them for use in treating some mental health disorders. 

But with this change comes questions. Who will benefit from their use? Who will be eligible? 

In today's episode of The Quicky, we speak to professionals to break down psychedelics for the treatment of mental health issues and whether this move really does open up the door to new treatments that could end the suffering of thousands. We also speak to a woman who lost her husband who's life may have been saved if he had access to these drugs. 

Subscribe to Mamamia

GET IN TOUCH

Feedback? We’re listening! Call the pod phone on 02 8999 9386 or email us at podcast@mamamia.com.au

CONTACT US

Got a topic you'd like us to cover? Send us an email at thequicky@mamamia.com.au

CREDITS 

Host: Claire Murphy

With thanks to: 

Tania De Jong - Founder of Mind Medicine Australia 

Dr Vince Polito - Senior Research Fellow at the School of Psychological Sciences at the Biomolecular Discovery Research Centre at Macquarie University 

Vanessa and Franco - thank you for sharing your story

Producer: Claire Murphy

Executive Producer: Kally Borg

Audio Producer: Thom Lion